X

Annals of Oncology

Annals of Oncology
ESMO Clinical Practice Guideline for the Diagnosis, Staging and Treatment of Patients With Metastatic Breast Cancer

This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing metastatic breast cancer.

Annals of Oncology
10/19/2021
Consolidation Nivolumab and Ipilimumab versus Observation in Limited-Disease Small Cell Lung Cancer After Chemo-Radiotherapy

Scientists demonstrate superiority of consolidation combination immunotherapy versus observation after chemo-radiotherapy plus PCI.

Annals of Oncology
09/22/2021
Nivolumab with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer

Nivolumab with carboplatin, paclitaxel, and bevacizumab is evaluated as first-line therapy for non-squamous NSCLC.

 

Annals of Oncology
06/14/2021
Deep Learning for Diagnosis and Survival Prediction in Soft Tissue Sarcoma

Clinical management of soft tissue sarcoma is particularly challenging. Here, investigators use digital pathology and deep learning for diagnosis and prognosis prediction of STS.

Annals of Oncology
06/14/2021
Zolbetuximab Plus EOX Versus EOX Alone for First-Line Treatment of Advanced CLDN18.2-Positive Gastric and Gastro-Oesophageal Adenocarcinoma

This phase II study evaluates clinical outcomes of zolbetuximab + EOX versus EOX alone in advanced CLDN18.2+ gastric cancer.

Annals of Oncology
05/01/2021
ESMO Recommendations on the Standard Methods to Detect RET Fusions and Mutations in Daily Practice and Clinical Research

New selective RET inhibitors have activity and favorable toxicity profiles in RET-altered solid tumors.

Annals of Oncology
03/01/2021
Checkpoint Inhibitor Therapy for Skin Cancer May be Safe in Patients With Asymptomatic COVID-19

An ongoing area of uncertainty during the SARS-CoV-2 pandemic is the safety of ICI therapy for cancer, and the theoretical possibility of exacerbated irAEs secondary to COVID-19 inflammatory pathol

Annals of Oncology
02/16/2021
Subscribe to Annals of Oncology

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
rgb (252, 186, 3)
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
rgb (132, 101, 173)
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834